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lthough human immunodeﬁciency virus type 1
(HIV-1) is generally thought to assemble at the
plasma membrane of infected cells, virions have
been observed in intracellular compartments in macrophages.
Here, we investigated virus assembly in HIV-1–infected
primary human monocyte-derived macrophages (MDM).
Electron microscopy of cryosections showed virus particles,
identiﬁed by their morphology and positive labeling with
antibodies to the viral p17, p24, and envelope proteins, in
intracellular vacuoles. Immunolabeling demonstrated that
these compartments contained the late endosomal marker
CD63, which was enriched on vesicles within these
structures and incorporated into the envelope of budding
virions. The virus-containing vacuoles were also labeled
A
 
with antibodies against LAMP-1, CD81, and CD82, which
were also incorporated into the viral envelope. To assess
the cellular source of infectious viruses derived from
MDM, virus-containing media from infected cells were
precipitated with speciﬁc antibodies. Only antibodies against
antigens found in late endosomes precipitated infectious
virus, whereas antibodies against proteins located primarily
on the cell surface did not. Our data indicate that most of
the infectious HIV produced by primary macrophages is
assembled on late endocytic membranes and acquires anti-
gens characteristic of this compartment. This notion has
signiﬁcant implications for understanding the biology of
HIV and its cell–cell transmission.
 
Introduction
 
Cell-free transfer and infection of cells by primate lenti-
viruses (HIV-1, -2, and SIV) requires the assembly and mat-
uration of infectious virus particles. Within an infected cell,
virions are formed in a temporally and spatially coordinated
manner wherein the components that make up the virus
(e.g., the virally encoded envelope, Gag, protease, integrase,
reverse transcriptase, and Vpr proteins, together with the
RNA genome) assemble in association with a specific cellular
membrane from which the viral envelope is derived. Previous
EM studies of infected lymphocytes or T cell lines in culture
have indicated that lentiviruses can assemble at, and bud
through, the plasma membrane of infected cells (Barre-Sinoussi
et al., 1983; Levy et al., 1984; Gelderblom et al., 1987). In
addition, analysis of purified human immunodeficiency
virus type 1 (HIV-1) indicates that, as well as the HIV-1
envelope glycoprotein (Env), glycoproteins found in the
plasma membrane of infected cells are also included in the
viral membrane (Tremblay et al., 1998; Esser et al., 2001;
Ott, 2002).
Despite the view that HIV assembly occurs at the plasma
membrane, a number of observations have suggested intra-
cellular organelles may also play a role in HIV-1 production.
First, virions and immature or budding HIV particles can
occasionally be observed in intracellular vacuoles, even in
infected T cell lines (unpublished data), though the nature of
these compartments and their role in the pathology of HIV
has not been established. Second, the cytoplasmic domain of
the HIV Env transmembrane component (TM or gp41)
contains a highly conserved tyrosine-based motif that can
mediate endocytosis of Env through clathrin-coated pits
(Rowell et al., 1995; Egan et al., 1996; Sauter et al., 1996;
Bowers et al., 2000). The presence of this signal results in the
majority of Env being located in intracellular membranes.
 
Experiments in polarized epithelial cells indicate the distribution
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of Env can have a dominant effect in determining the site of
virus assembly (Lodge et al., 1997). Significantly, disruption
of the endocytosis signal in an infectious SIV model leads to
attenuation of viral pathogenesis (Fultz et al., 2001). Third,
the budding of HIV and some other enveloped viruses uses
host cell machineries that normally function in the topologi-
cally similar formation of the small internal vesicles of multi-
vesicular bodies (MVBs; for review see Pornillos et al., 2002).
HIV particles budding at the cell surface would need to re-
cruit these so-called ESCRT complexes to the plasma mem-
brane, whereas the presence of the ESCRT complexes on en-
dosomes may favor intracellular virus assembly.
Here, we have investigated HIV-1 assembly in infected
monocyte-derived macrophages (MDM), a primary cell
preparation in which virus has previously been demon-
strated to accumulate in intracellular compartments (Gen-
delman et al., 1988; Orenstein et al., 1988). Although origi-
nally suggested to be derived from the Golgi apparatus,
recent studies have indicated that the virus-containing struc-
tures in these cells are equivalent to the major histocompati-
bility antigen type II compartment (MIIC) in which ma-
turing major histocompatibility antigen type II (MHCII)
molecules are loaded with peptides (Raposo et al., 2002).
Here, we confirm these observations and show that in hu-
man primary MDM, at least two strains of HIV-1 assemble
in intracellular vacuoles at all time points examined, whereas
little (if any) virus assembly is seen at the plasma membrane.
Using immunolabeling of cryosections, we demonstrate that
these intracellular virus-containing vacuoles have character-
istics similar to those described for multivesicular late endo-
somes; they can contain small internal vesicles, and they can
be immunolabeled with antibodies against markers for late
endosomes. HIV-1 virions were observed to bud directly
into this compartment and thereby acquire late endosome
membrane proteins, notably CD63 and LAMP-1. MDM
were also observed to secrete virions into the culture me-
dium when the virus-containing intracellular vacuoles fused
with the plasma membrane. Immunoprecipitation of virus-
containing media from infected MDM with antibodies di-
rected against intracellular and cell surface markers demon-
strated that most of the infectious HIV released from these
cells is produced in an intracellular late endosome compart-
ment, and not at the cell surface.
 
Results
 
Infection of MDM with HIV-1
 
Monocytes were derived from human peripheral blood by
adherence and were differentiated in culture for 6 d. At
Figure 1. Time course of HIV-1 Ba-L production in MDM. Human 
MDM were infected with 9.3   10
5 focus-forming units (FFU) of 
HIV-1 Ba-L. Supernatants were collected daily and analyzed for (A) 
p24 content ( ) or reverse transcriptase ( ) and (B) infectivity on 
NP-2 CD4/CCR5 indicator cells. Activities are corrected for the 
dilution effect of feeding.
Figure 2. Overview of anti-p24 and -p17 staining on HIV-infected 
MDM. Semi-thin cryosections of MDM infected with HIV-1 Ba-L 
and labeled with anti-p24 (A–D), or infected with HIV-1 SF162 and 
labeled with anti-p17 (E–G), were stained with Alexa
® Fluor 488 
goat anti–mouse IgG. Cells had been infected for 7 (A), 12 (B), 15 
(C), and 20 d (D); or 14 (E), 21 (F), and 30 d (G). Bars, 10  m.T
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this time, the cultures consisted primarily of macrophages,
with 
 
 
 
90% of the cells positive for the macrophage
marker CD14. These MDM could be infected with CCR5
(R5) tropic HIV-1 strains and could be kept in culture for
up to 30 d.
To assess the time course of the infections, supernatants
were collected from MDM cultures infected with HIV-1
Ba-L, and the amount of released virus was determined by
measuring levels of viral capsid, p24, or reverse transcriptase
activity (Fig. 1 A). The infectivity of the released viruses was
tested in a focus-forming assay after infection of susceptible
NP-2 target cells (Fig. 1 B). Virus could be detected in the
MDM medium as early as 3 d after infection and accumu-
lated rapidly over the following days. The amount of infec-
tious virus released reached a maximum at 8 d after infection
and was maintained thereafter. Measurement of p24 concen-
tration and reverse transcriptase activity demonstrated that
the cells continued to release virus for a further two weeks.
 
Localization of HIV antigens in infected MDM
 
To study virus assembly, MDM infected with HIV-1 Ba-L
for various times were prepared for cryosection immunola-
beling, and semi-thin sections (0.5 
 
 
 
m) were analyzed for
expression of viral antigens by fluorescence microscopy. Vi-
ral capsid (p24) and matrix (p17) antigens were detected in a
large proportion of the cells at all times. At 7 to 20 d, stain-
ing with the anti-p24 antibody, which also detects the Gag
polyprotein precursor p55, was seen associated with intracel-
Figure 3. Intracellular HIV-1 in MDM. Cryo-
sections from MDM infected with HIV-1 Ba-L were 
stained with anti-p17 (A and A ) or anti-p24 anti-
bodies (B and B ) and 10 nm PAG. Alternatively, 
sections were double labeled for p24 (PAG 5 nm) 
and p17 (PAG 10 nm) (C and C ). Virus particles 
were found primarily in intracellular vacuoles at 
all times, i.e., in these cells infected for 7 (B ), 
12 (A ), 14 (A and B), or 20 d (C and C ). Arrows 
identify budding or immature virions in A , B , or 
C . D shows a cell infected with HIV-1 SF162 for 
14 d, stained with anti-p24 and PAG10. Note the 
small unlabeled internal vesicles (C and D, white 
arrowheads) and the flat coat on some of these 
vacuoles (B and D, black arrowheads). Bars, 100 nm.T
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lular granules (Fig. 2, A–D), and only rarely were small spots
or patches of fluorescence detected at or close to the cell sur-
face. Similar results were obtained with MDM infected with
another macrophage-tropic HIV-1 strain (SF162) for 14,
21, or 30 d. Labeling with an anti-matrix (p17) mAb identi-
fied this viral antigen in intracellular spots and clusters (Fig.
2, E–G), but not at the cell surface. Thus, HIV-1 appears
to accumulate predominantly intracellularly in MDM, in
agreement with previous reports (Orenstein et al., 1988; Ra-
poso et al., 2002). Similar results were obtained with MDM
infected with the SL-2 and JR-FL strains of HIV-1, though
the proportion of infected cells in these cultures was lower.
 
EM analysis of the virus-containing 
compartments in MDM
 
To study the intracellular viral antigens in more detail, ul-
trathin cryosections (
 
 
 
50 nm) of infected MDM were la-
beled with antibodies against p17 or p24 and protein A gold
(PAG) and observed by EM. These antibodies stained elec-
tron-dense 100–110-nm membrane-containing particles, of-
ten with truncated cone-shaped cores typical of mature
HIV-1 (Fig. 3). Anti-p17 antibody labeling was often seen
close to the membrane of these particles (Fig. 3 A), but was
absent over budding figures or particles with the appearance
of immature virions, consistent with this antibody recogniz-
ing only the cleaved Gag protein (Fig. 3 A
 
 
 
; Ferns et al.,
1987). Anti-p24 showed strong labeling over particles with
the appearance of both immature and mature virions, with
up to 20–30 gold particles per virus particle (Fig. 3, B and
B
 
 
 
). The different distributions of the p17 and p24 antigen
were confirmed on sections double labeled with these anti-
bodies (Fig. 3, C and C
 
 
 
).
Labeled virus particles were seen in intracellular vacuoles,
often quite deep in the cell. The presence of occasional bud-
ding figures and what appeared to be immature virions (Fig.
3, A
 
 
 
, B
 
 
 
, and C
 
 
 
) indicated that particles containing the
p24/p55 Gag protein assembled at the limiting membranes
of these intracellular structures. Vacuoles containing the
p17- and p24-labeled particles displayed a variety of sizes,
from large organelles packed with these particles (Fig. 3 B) to
more loosely filled structures (Fig. 3 C), narrow tubules (Fig.
3 C
 
 
 
), or complex intracellular membrane systems. Although
some vacuoles contained mainly the labeled particles, others
also had internal membrane structures, including small vesi-
cles similar to those found in MVBs (Fig. 3 C). Frequently,
the virus vacuoles contained a prominent electron-dense flat
coat (Fig. 3, B and D) which, at 
 
 
 
28 nm (range 25–30 nm),
was significantly thicker than the coats lining clathrin-coated
pits at the plasma membrane (
 
 
 
17–23 nm on these prepara-
tions). Only rarely were p24/p17-labeled particles found at
or close to the plasma membrane. The distribution of these
virus-like particles mainly in intracellular vacuoles was not a
property unique to the Ba-L virus, as another HIV-1 strain
(the macrophage-tropic SF162) also accumulated in similar
intracellular compartments (Fig. 3 D).
 
Envelope expression on intracellular HIV-1 virions
 
When cryosections of HIV-1 Ba-L–infected MDM were
stained with an antibody against the gp120 component of
HIV-1 Env (2G12), strong labeling was observed over intra-
cellular particles morphologically identical to those labeled
for p24 and/or p17 (Fig. 4 A). These particles were labeled
with, on average, five gold particles per virion, suggesting
that they had incorporated significant levels of Env. Simi-
larly, viruses could be labeled with another anti-Env anti-
body (b12), though the labeling was not as strong (unpub-
lished data). Double staining confirmed that Env was
enriched on p24-containing particles (Fig. 4 B), consistent
with the possibility that these particles are infectious viruses.
On the 2G12-stained cryosections, the intracellular virus
particles were by far the most strongly labeled structures.
However, some labeling was seen on other structures includ-
ing various tubules, vacuoles, or membrane cisternae, often
found in the vicinity of the Golgi apparatus/TGN. Only low
levels of labeling were observed at the plasma membrane.
 
Identification of the virus-containing vacuoles 
as late endosomes
 
To identify the intracellular vacuoles into which the Env/
p24-labeled virus particles were budding, we colabeled ul-
trathin cryosections with antibodies against various intracel-
lular markers. Recent analyses of HIV-1–infected macro-
phages indicated that the MHCII protein HLA-DR is
Figure 4. Detection of HIV-1 envelope on intracellular HIV-1 
virions in MDM. Cryosections from MDM infected with HIV-1 Ba-L 
for 14 d were stained with anti-Env 2G12 and PAG10 (A) or double 
labeled for p24 with PAG5 and Env with PAG10 (B). The inset in A 
shows a detailed view with gold particles over the viral membrane 
on equatorially sectioned virions, or all over virions cut more 
tangentially. Bars, 100 nm.T
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incorporated into virions budding into MIICs (Raposo et
al., 2002). Because MIICs are a specialized late endosome
compartment, we stained infected MDM with antibodies
against CD63, a tetraspanin found in late endosomes and
MVBs, particularly in the membranes of the internal vesi-
cles. In macrophages, a small amount of CD63 is also found
at the plasma membrane. On MDM cryosections, virus-
containing vacuoles were strongly labeled with anti-CD63
(Fig. 5). Gold particles identified CD63 within the envelope
of individual virions, as well as over small membrane vesicles
similar to the internal vesicles of MVBs (Fig. 5 A). This sug-
gests that the compartment into which HIV-1 is budding in
MDM is equivalent to the late endosome/MVB compart-
ment. The MDM used in these analyses did not contain
many classical MVBs, with numerous internal vesicles, simi-
lar to those found in tissue culture cell lines. Instead, anti-
CD63 strongly labeled various small membrane vacuoles,
vesicles, and tubular profiles that contained few internal ves-
icles. Virions were seen to bud into these compartments, in-
corporating CD63 into their membrane envelope as they as-
sembled at the limiting membrane (Fig. 5 C).
We also stained MDM with antibodies against lysosomal
markers. Although antibodies against LAMP-1, LAMP-2, or
the macrophage-specific lysosomal glycoprotein CD68/mac-
rosialin occasionally identified electron-dense lysosomes, the
majority of the labeling was found over small vacuoles and
membrane tubules, some of which contained internal vesi-
cles or other structures similar to those labeled with anti-
CD63. The anti-LAMP-1 antibody showed strong labeling
on cryosections and was seen over the virus-containing vacu-
oles (Fig. 6), occasionally even over viral envelopes (Fig. 6, A
and C). However, labeling of the virus-containing vacuoles
was weak compared with virus-negative, LAMP-1–labeled
membrane tubules and vesicles that were frequently found
nearby (Fig. 6, A and B). This was clear in triple labeling,
where sections were costained for viral p17, CD63, and
LAMP-1 (Fig. 6 C). Although high levels of CD63 were as-
sociated with virus vacuoles and found over the virions, the
level of LAMP-1 labeling over this compartment was low.
This suggests that the CD63-containing virus vacuoles rep-
resent a late endosome compartment, which differs from the
LAMP-1–enriched membranes nearby. Other lysosomal
markers such as LAMP-2 or CD68 were expressed at much
lower levels than LAMP-1 in these MDM. Nonetheless,
these markers were also occasionally found associated with
virus-containing vacuoles (Fig. 7 A; unpublished data).
Because CD63 was enriched on viruses, and because other
tetraspanins have been found in the internal vesicles of
Figure 5. HIV-1 virions in MDM accumulate in 
CD63-containing compartments. Cryosections 
from MDM infected with HIV-1 Ba-L for 14 d were 
double labeled for p24 with PAG5 and for CD63 
with PAG15. (A) Overview of a large complex 
intracellular vacuole filled with virions and clusters 
of small vesicles containing CD63 (white arrow-
heads). Virions are identified by PAG5 and are 
frequently labeled with the larger gold particles 
marking CD63 (e.g., at the large arrows), whereas 
the small vesicles are labeled only with CD63/
PAG15. (B) A smaller vacuole containing virus 
particles also labeled with CD63/PAG15. Note the 
electron-dense coat (black arrowheads). (C) Virions 
budding into a complex vacuole labeled with 
anti-CD63. Small arrows indicate budding virus 
particles incorporating CD63 into their membranes. 
Bars, 100 nm.T
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MVBs (Escola et al., 1998), we stained MDM with antibod-
ies against two other tetraspanins, CD81 (Fig. 7 B) and
CD82 (Fig. 7 C). These proteins can be found on the
plasma membrane of MDM, but were also seen to be associ-
ated with the virus-containing vacuoles. In particular, CD81
labeled the virus vacuoles strongly and could be seen associ-
ated with viral envelopes (Fig. 7 B). CD82 had a similar dis-
tribution, though the staining was weaker (Fig. 7 C).
These analyses suggest that in MDM, HIV assembles in
intracellular vacuoles containing markers for late endosomes
and MVBs. As the virus buds into this compartment, it ac-
quires various cellular proteins characteristic of late endo-
somes/MVBs into its envelope, including the tetraspanins
CD63, CD81 and CD82, and some LAMP-1.
 
Virus precipitation with antibodies against 
cellular proteins
 
HIV-infected MDM cultures release infectious virus into the
medium (Fig. 1 B). Our EM observations suggest that the
majority of HIV particles produced by MDM are assembled
Figure 6. Virus-containing vacuoles in MDM 
labeled with antibodies to LAMP-1. (A) Cryosections 
from MDM infected with HIV-1 Ba-L for 7 d were 
labeled with a rabbit antiserum to LAMP-1 and 
PAG10. Note gold labeling associated with the 
large virus-containing vacuole, including gold 
particles on individual virions (white arrowheads). 
However, lysosomal membranes nearby contain 
significantly more gold particles (arrows). (B) Cryo-
section double labeled with rabbit anti-LAMP-1/
PAG5 and anti-p17/PAG10. The large virus-
containing vacuole contains many p17-labeled 
virions, whereas a few 5 nm gold particles identify 
associated LAMP-1 (e.g., at the white arrowheads). 
More strongly LAMP-1–labeled membranes are 
observed nearby (arrow). (C) A large virus vacuole 
triple labeled with anti-p17/PAG5, anti-CD63/
PAG10, and rabbit anti-LAMP-1/PAG15. Many 
virions are labeled with the anti-CD63/PAG10 
(black arrowheads), and some also contain a few 
LAMP-1/PAG15 particles, some of which are 
identified by white arrowheads. The rare, small 
internal vesicles contain just CD63 (small arrows). 
CD63 and LAMP-1–labeled membranes are also 
observed nearby (large arrows). Bars, 100 nm.T
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in late endosomes. Whether these are the source of the infec-
tious virus in the cells’ media is not clear. To determine the
cellular origin of the infectious HIV derived from MDM, we
precipitated viruses collected from MDM culture media
with antibodies directed against ectodomain epitopes of a
number of transmembrane and GPI-linked proteins associ-
ated with intracellular and/or plasma membranes (Table I).
The selection of these proteins was based on their reported
expression in specific membrane systems and/or their pres-
ence in HIV-1 envelopes (Tremblay et al., 1998; Ott, 2002).
Expression of the antigens and their cellular distribution was
determined on (or in) MDM by FACS
 
®
 
 analysis and by im-
munofluorescent staining of fixed infected and uninfected
MDM cultures or of semi-thin cryosections (Table I).
Cell-free media from HIV-1 Ba-L–infected MDM were
mixed with the respective antibody and subsequently bound
to fixed 
 
Staphylococcus aureus
 
. Samples were centrifuged to
produce a pellet and a supernatant. The supernatants were
analyzed for unprecipitated infectious virus by infecting NP-2
cells. Both the pellet and supernatant were assayed for viral
p24 by ELISA. As positive controls for precipitation, we
used the anti-Env antibody b12 as well as an anti-HLA-DR
antibody, as HLA-DR has been reported to be readily incor-
porated into macrophage-derived HIV-1 Ba-L (Esser et al.,
2001). An antibody against the vesicular stomatitis virus gly-
coprotein (VSV-G) was used to determine nonspecific virus
precipitation.
Nonspecific precipitation of infectious virus was low, as
the anti-VSV-G antibody produced only a small (
 
 
 
10%) re-
duction in the number of infectious focus-forming units
(FFU; unpublished data). By contrast, precipitation with the
anti-Env antibody completely eliminated infectivity in the
supernatant. The antibody against the cellular protein HLA-
DR also precipitated a significant amount of infectious virus,
in agreement with previous reports that this protein is incor-
porated into the HIV-1 envelope (Esser et al., 2001; Raposo
et al., 2002). Of the antibodies against tetraspanin markers,
anti-CD63 showed the most efficient removal of infectious
virus from the supernatant; this was observed with two dif-
ferent anti-CD63 antibodies (Table I). The other tetraspanin
antibodies, anti-CD81, -CD82, -CD53, and -CD151 also
precipitated some of the infectious virus, though much less
efficiently, suggesting that not all virus particles incorporated
sufficient levels of these molecules into their envelopes for
immunoadsorption to occur (Fig. 8 A). Precipitation with
antibodies against LAMP proteins showed that LAMP-1 was
incorporated into some of the infectious virus, but LAMP-2
was not detectable (Table I). Antibodies against well-charac-
terized cell surface proteins, including GPI-anchored pro-
teins (CD14, CD52, and CD55) and various adhesion pro-
teins (CD11a and CD169), did not precipitate significant
amounts of infectious virus. However, some HIV infectivity
was removed by antibodies to the GPI-anchored protein
CD59, and by CD54 (ICAM-1; Fig. 8 A and Table I).
Measurement of the amount of viral p24 precipitated by
these antibodies showed a corresponding result, as low levels
of the viral protein were precipitated with the VSV-G anti-
body and high amounts with the anti-Env and -HLA-DR
antibodies (Fig. 8 B). This demonstrates directly that the
anti-Env antibody b12, a neutralizing antibody (which
could account for the observed reduction of infectious vi-
rus), is able to precipitate the virus (Fig. 8 A). The anti-
CD63 antibodies precipitated similar levels of p24 as the
Env antibody, confirming that the majority of virus incor-
porates CD63 in its envelope (Fig. 8 B and Table I). The
anti-CD81 antibody precipitated comparable amounts of vi-
ral protein to the anti-CD82 and -CD53 antibodies, al-
though it did not remove as many infectious particles from
the supernatant (compare Fig. 8 B with Fig. 8 A). The
Figure 7. Cellular markers associated with virus-containing vacuoles 
in MDM. (A) Cryosections of MDM infected with HIV-1 Ba-L were 
double labeled with rabbit anti-LAMP-2 and PAG10, and virions 
were identified with anti-p17/PAG15. LAMP-2 was not highly 
expressed on these MDM, and hence only few gold particles could 
be observed, but there was some labeling of virus-containing vacuoles 
(white arrowheads). In addition, a lysosome (L) and membrane 
tubules are labeled nearby (arrow). (B and C) Cryosections of MDM 
infected with HIV-1 Ba-L were double labeled with antibodies against 
CD81 (B) or CD82 (C), whereas virions were identified with anti-p17. 
Both CD81 and CD82 are associated with the virus-containing 
vacuoles and can sometimes be found on the virions (black arrow-
heads). Labeling with anti-CD81 is significantly stronger than with 
anti-CD82. Bars, 100 nm.T
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CD151 antibodies did not precipitate detectable levels of
p24. Pellets of precipitates with anti-LAMP-1, but not
with anti-LAMP-2, contained viral p24 (Table I). Antibod-
ies against various cell surface proteins including CD14,
CD11a, and CD54 failed to precipitate a significant amount
of viral p24 (Fig. 8 B and Table I). Out of all these cell sur-
face markers, only antibodies to the GPI-linked protein
CD59 were able to precipitate some p24.
Together, these results show that virtually all the infec-
tious HIV-1 that accumulated in the media of the MDM
had acquired late endosome–associated proteins, in particu-
lar CD63, whereas the infectious virions were devoid of a
number of cell surface markers. Together with the EM ob-
servations, these data suggest that all the infectious HIV and
most (if not all) virus particles released from HIV-infected
MDM are derived from late endosomes/MVBs.
 
Virus release from infected MDM
 
In hematopoietic cells, late endocytic compartments can
function as secretory organelles (Blott and Griffiths, 2002).
Moreover, MIICs have been proposed to fuse with the
plasma membrane, either directly or via membrane tubules
(Raposo et al., 1996; Boes et al., 2002; Chow et al., 2002).
Our EM observations of infected MDM suggested that such
a mechanism might provide a route for virus release. Virions
were not generally found on the surface of the infected cells,
but occasionally accumulations of virions were seen in invag-
inations or deep pockets of the plasma membrane (Fig. 9).
The virions in these invaginations were often interspersed
with small vesicles resembling exosomes, the MVB-derived
vesicles released by certain hematopoietic cells when their
MVBs fuse with the plasma membrane (Stoorvogel et al.,
2002; Thery et al., 2002), which could be labeled with anti-
bodies against LAMP-1 and CD63 (Fig. 9). This suggests
that the plasma membrane pockets represent exocytic pro-
files resulting from the fusion of the virus-containing vacu-
oles with the cell surface. Thus, in human MDM, infectious
HIV-1 is produced in intracellular compartments with fea-
tures of late endosomes or MVBs, and these viruses can be
released to the extracellular medium by secretion.
 
Table I. 
 
Immunoprecipitation of HIV-1 Ba-L–containing supernatant media from infected MDM cultures
Virus precipitation Expression in MDM
Percentage of 
infectivity in 
supernatant
 
a
 
Percentage of 
p24 precipitated
 
n
 
b
 
Cell surface
 
c
 
Intracellular
 
d
 
Viral antigens
 
HIV-1 Env (b12) 0.3 
 
 
 
 0.7 92.2 
 
 
 
 8.1 5 ND ND
Control  100 14.2 
 
 
 
 2.7 5
 
  
 
MHCII
 
HLA-DR 29.4 
 
 
 
 8.4 79.6 
 
 
 
 4.3 5
 
      
 
Tetraspanin
 
CD63 (1B5) 5.6 
 
 
 
 2.1 95.5 
 
 
 
 3.4 4
 
      
 
CD63 (FC5.01) 6.6  100 1 ND
 
    
 
CD81 84.5 
 
 
 
 9.5 39.6 
 
 
 
 16.5 3
 
      
 
CD82 75.1 
 
 
 
 18.8 51.2 
 
 
 
 7.0 3
 
  
 
CD53 58.7 
 
 
 
 8.0 58.6 
 
 
 
 16.3 3
 
  
 
ND
CD151 85.0 
 
 
 
 21.3 12.2 
 
 
 
 5.5 3
 
      
 
Lysosome associated
 
LAMP-1 54.5 40.2 1
 
     
 
LAMP-2 115.8 21.2 1
 
    
 
GPI anchored
 
CD14 87.8 
 
 
 
 16.8 11.9 
 
 
 
 7.3 3
 
      
 
CD52 94.6 
 
 
 
 11.6 18.4 
 
 
 
 8.0 3
 
      
 
CD55 88.3 
 
 
 
 16.7 9.5 
 
 
 
 5.2 3
 
     
 
CD59 45.4 
 
 
 
 17.6 67.0 
 
 
 
 9.0 3
 
 
 
/
 
  
 
Adhesion
 
CD11a 110.3 
 
 
 
 28.4 18.4 
 
 
 
 5.1 3
 
      
 
CD54 56.3 20.0 1
 
   
 
ND
CD169 96.8 
 
 
 
 17.5 17.5 
 
 
 
 1.7 3
 
      
 
Scavenger receptor
 
CD163 103.2 
 
 
 
 20.3 17.1 
 
 
 
 4.4 3
 
     
 
ND, not determined.
 
a
 
To calculate the percentage of infectivity in the supernatant, the infectivity of samples treated with the control antibody against VSV-G was set at 100%.
 
b
 
Number of experiments.
 
c
 
Determined by FACS
 
®
 
 analysis or by immunofluorescence.
dDetermined by immunofluorescence staining of semi-thin cryosections or of permeabilized cells.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
 Infectious HIV-1 assembly in endosomes | Pelchen-Matthews et al. 451
Discussion
Enveloped viruses have to assemble on, and bud through, a
cellular membrane to acquire their own membrane. For
HIV and related viruses, this budding has been, in the main,
considered to occur at the plasma membrane of infected
cells, possibly involving particular cell surface microdomains
(Ono and Freed, 2001). These views have prevailed despite
the fact that soon after the discovery of HIV, ultrastructural
analysis of infected monocytes and macrophages showed the
presence of virions in intracellular vacuoles in the vicinity of
the Golgi apparatus (Gendelman et al., 1988; Orenstein et
al., 1988). Now, we have used immunolabeling of ultrathin
cryosections with specific antibodies directed against not
only the viral Gag and Env proteins, but also a number of
well-defined cellular antigens, to examine virus assembly in
more detail. Our analyses confirm that in primary human
MDM, multiple R5-tropic HIV-1 strains assemble into and
accumulate in intracellular vacuoles. The virus-containing
compartment is not part of the Golgi complex or TGN, but
instead has the properties of late endosomes/MVBs, in
agreement with the observations of Raposo et al. (2002),
who showed that in MDM, HIV assembly occurs in the late
endocytic MIIC compartment. Furthermore, using immu-
noprecipitation, we show that the majority of the infectious
virus derived from cultured MDM assembles in these or-
ganelles, and not at the plasma membrane.
In macrophages and other antigen-presenting cells, the
endocytic pathway, in particular late endosomes and lyso-
somes, is morphologically and functionally complex, with
roles requiring the degradative properties of conventional
lysosomes as well as the secretory functions of exocytic or-
ganelles. Classical MVBs were rare in the MDM that we
studied, but various tubular and cisternal membranes were
labeled with markers frequently associated with late endo-
somes and lysosomes, including CD63 and LAMP-1. The
morphology of these organelles resembles the tubular lyso-
somes previously described in macrophages (for review see
Rabinowitz et al., 1992). The virus-containing vacuoles had
a complex morphology and frequently contained a few
small vesicles resembling the internal vesicles of MVBs. Vi-
rus-containing vacuoles were characterized by high levels of
CD63. In addition, they contained LAMP-1 and, to a lesser
extent, LAMP-2 and the macrophage-specific lysosomal
membrane glycoprotein CD68. However, they did not rep-
resent the main LAMP-1–labeled compartment in the
MDM cells. Electron-dense lysosomes were only rarely ob-
served, and most of the cellular LAMP-1 labeling was seen
over tubular and vesicular membrane elements, which were
frequently seen close to virus-containing vacuoles. Thus,
the CD63
high/LAMP-1
low virus-containing compartment
may represent an earlier endocytic compartment to the
LAMP-enriched tubular lysosomes, i.e., a compartment
equivalent to late endosomes or MVBs. The late endosomal
lipid lysobisphosphatidic acid (LBPA) could not be de-
tected in our MDM preparations (unpublished data);
whether MDM lack LBPA or express an antigenic variant
of LBPA that does not react with the 6C4 antibody (Koba-
yashi et al., 1998) is unclear.
Another characteristic of the intracellular virus-containing
vacuoles were thick, electron-dense coats that frequently ex-
tended over a large proportion of the cytoplasmic aspect of
the vacuole membrane (Fig. 3 D). The nature of these coats
is not clear. They were thicker than the clathrin coats ob-
served at the cell surface, did not show the “bilayered” ap-
pearance of endosomal clathrin coats containing Hrs (for
review see Sachse et al., 2002), and were not labeled with
anti-clathrin antibodies (unpublished data). Given that the
intracellular budding of HIV and the formation of the inter-
nal vesicles of MVBs are topologically similar and require the
same cellular ESCRT machinery (Garrus et al., 2001; Por-
nillos et al., 2002; Freed, 2003), it is possible that these coats
contain components of ESCRT complexes. In T cells, where
the majority of virus assembly occurs at the plasma mem-
brane, these cellular components would have to be recruited
to the cell surface, but why virus is generated at different
sites in these different cell types is at present unclear.
Figure 8. Virus precipitation with antibodies against cellular 
proteins. Cell-free supernatants of MDM-derived HIV-1 Ba-L were 
precipitated with the antibodies indicated. Unprecipitated supernatants 
were analyzed for remaining infectious virus by a focus-forming 
assay on NP-2 CD4/CCR5 cells (A). Pellets were analyzed for pre-
cipitated viral protein by p24 ELISA (B).T
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In contrast to studies with macrophage-derived HIV-1
Ada, which contained only very low levels of Env (Orenstein
et al., 1988; Meltzer et al., 1990), our immunolabeling ex-
periments suggested that the intracellular virions observed in
MDM acquired significant amounts of Env. Indeed, on
many anti-Env–stained sections, the intracellular virions
represented the most strongly labeled structures, suggesting
that Env is enriched on the budding virions. How these Env
levels compare with those in viruses budding from the cell
surface in other cell types is under investigation. The Env
proteins of primate immunodeficiency viruses contain at
least one conserved endocytic sorting signal in their cyto-
plasmic domains (Rowell et al., 1995; Egan et al., 1996;
Sauter et al., 1996; Bowers et al., 2000; Wyss et al., 2001),
which accounts for the low levels of surface Env seen in our
labeling experiments, but how Env is sorted into the endoso-
mal budding profiles is unknown. The fact that high levels
of Env are apparent on virions assembling into late endo-
somes suggests these particles are likely to be infectious.
In addition to the viral Env protein, HIV virions also ac-
cumulate a number of cellular glycoproteins into their mem-
branes, most notably CD63, as well as CD81 and CD82,
and some LAMP-1. Furthermore, HIV-1 has been shown to
acquire MHCII (HLA-DR) in this compartment (Raposo et
al., 2002). It has been known for some time that HIV incor-
porates a number of other cellular proteins into its envelope
(Tremblay et al., 1998; Esser et al., 2001; Ott, 2002). These
have been proposed to facilitate infection, and viruses con-
taining HLA-DR have been reported to be more infectious
(Cantin et al., 1997a,b). Whether the inclusion of late endo-
somal proteins such as CD63 has any role in virus transmis-
sion is not known, though CD63 in the viral membrane
may contribute to the ability of anti-CD63 antibodies to in-
hibit HIV infection of macrophages (von Lindern et al.,
2003).
The inclusion of late endosomal proteins in the viral
membrane offers a useful experimental marker to facilitate
the identification of the cellular source of infectious virus re-
leased from MDM. When infected MDM are homogenized,
the number of infectious particles in the supernatant is in-
creased significantly, suggesting that a large intracellular
pool of infectious virus does exist in these cells (unpublished
data); however, infectious virus can also be collected from
the media of infected MDM. Because it was possible that
this might include virus that assembled at the cell surface,
but was not detected in our EM analysis, we tried to identify
the source of infectious particles in the tissue culture media
by analyzing the composition of the virions using immuno-
precipitation analysis. These experiments demonstrated that
the virions were derived from an intracellular compartment
because markers for internal proteins, which have been
shown by EM to be present on the intracellular virus parti-
cles, can precipitate virus. Most notable among these was
CD63, which consistently removed  95% of the infectious
particles from the medium. Although the MDM express low
levels of CD63 at the PM, the majority of this protein was
found in the intracellular late endosome compartment,
where we have seen it to be incorporated into budding viri-
ons. Similarly, virions could be precipitated with an anti-
body to HLA-DR, another marker incorporated into virions
as they bud into this intracellular compartment (Raposo et
al., 2002). The late endosome/lysosome protein LAMP-1
Figure 9. Exocytosis of virions on infected MDM. 
Plasma membrane invaginations probably resulting 
from the fusion of intracellular virus-containing 
vacuoles with the plasma membrane. Cryosection 
in A was double labeled for LAMP-1/PAG5 and 
p17/PAG10, whereas B was triple labeled for p17/
PAG5, CD63/PAG10, and LAMP-1/PAG15. Al-
though these invaginations are continuous with the 
cell surface, they show labeling for LAMP-1 (white 
arrowheads) and CD63. Virions are interspersed 
with many small vesicles (black arrows) that are 
strongly labeled for CD63 (B, black arrows). 
Also, note the thick electron-dense coats on some 
parts of these invaginations (black arrowheads). 
Bars, 100 nm.T
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also precipitated some infectious HIV-1, as did antibodies
against CD81 and CD82, markers that were also shown by
EM to be associated with intracellular virions. By contrast,
antibodies against cell surface markers including CD11a,
CD52, CD55, CD163, CD169, and the macrophage-spe-
cific CD14 all failed to precipitate significant amounts of in-
fectious virus (Fig. 8 and Table I). Interestingly, antibodies
against CD59 and CD54 precipitated infectious virus. Al-
though usually considered to be plasma membrane markers,
recent work indicated that both of these antigens can be in-
corporated into exosomes, and thus must be present in late
endosomes/MVBs (Thery et al., 2002; Clayton et al., 2003).
Previous reports comparing HIV derived from different cell
types noted that macrophage-derived viruses may exclude
some cell surface markers, compared with T cell–derived vi-
rus, consistent with the former undergoing intracellular as-
sembly (Esser et al., 2001).
Our experiments show that in infected MDM, HIV is as-
sembled in late endosomes and is subsequently released to the
medium, most likely by fusion of the virus-containing vacu-
oles with the plasma membrane (Raposo et al., 2002). In-
deed, virion-filled deep invaginations of the plasma mem-
brane could sometimes be observed (Fig. 9). Although these
might represent phagocytic structures or specialized plasma
membrane virus assembly zones, several observations argue
against this. First, if the invaginations were associated with
phagocytosis of virions from the media, they might be ex-
pected to be seen on all cells, but they were mainly found on
cells with intracellular virus vacuoles. Second, few virions
were found near the surface of MDM, so it is unclear how vi-
rus particles might be concentrated into these structures.
Third, the virions were frequently interspersed with small ves-
icles resembling exosomes that labeled strongly with antibod-
ies to CD63 (Fig. 9 B). Hence, these pockets are more likely
to be exocytic profiles resulting from the fusion of virus-con-
taining vacuoles with the cell surface. Apart from these pro-
files, very few virions were seen at the plasma membrane.
In many cells, compartments of the late endocytic path-
way have some capacity to undergo regulated exocytosis
(Andrews, 2000), but in hematopoietic cells, these or-
ganelles have specialized secretory functions (Blott and Grif-
fiths, 2002). In antigen-presenting cells, MIICs or MIIC-
derived tubules can fuse with the plasma membrane to in-
crease MHCII expression at the cell surface (Chow et al.,
2002). The virus-containing vacuoles in MDM may also be
secretory organelles, and virus release might be triggered by
specific stimuli to the cells. Indeed, it has been shown that
macrophages can release virions onto epithelial cell mono-
layers (Bourinbaiar and Phillips, 1991). Directed secretion
of virions could be particularly important during antigen
presentation, when macrophages present loaded MHCII to
T cells. As a macrophage stimulates the T cell, reverse signal-
ing from the T cell to the macrophage may induce directed
release of virions onto the T cell target. Thus, macrophage
transmission of HIV may be mechanistically similar to the
proposed sequestration and release of virus from dendritic
cells. These cells can sequester virus, possibly in an endo-
some compartment, without themselves becoming infected,
and subsequently release virus during their interactions with
T cells (Kwon et al., 2002; McDonald et al., 2003).
Macrophages play a crucial role in HIV infection and
AIDS. They are among the first cells infected by HIV, and
have been found to be less susceptible to the cytopathic ef-
fects of HIV and more resistant to HIV-induced apoptosis,
allowing them to survive for a long time (weeks to months)
after infection (Herbein et al., 2002; Kedzierska et al.,
2003). Infected macrophages, laden with infectious virions,
can potentially pass virus onto T cells during antigen presen-
tation. In addition, virions assembled intracellularly in mac-
rophages may differ from T cell–released virus in their spec-
trum of host-derived molecules, as well as, perhaps, in the
amount of Env expressed, and therefore, in their infectivity.
Because macrophages are a major reservoir for HIV-1 in in-
fected individuals, the intracellular assembly of virus in these
cells may be an important component of pathogenesis in
vivo. Our analyses suggest a key role for late endosomes in
the biogenesis of HIV. The full functional significance of
this is a focus for ongoing investigation.
Materials and methods
Reagents
Tissue culture reagents and Nunc tissue culture plastic were from Invitro-
gen. EM chemicals were from Agar Scientific and TAAB Laboratories.
Other chemicals were from Sigma-Aldrich, unless otherwise indicated.
The antibodies used in this work, and their sources, are listed in Table SI
(available at http://www.jcb.org/cgi/content/full/jcb.200304008/DC1).
Cells and infections
Peripheral blood mononuclear cells were isolated from buffy coats of
healthy, HIV-1 seronegative donors (National Blood Service, Essex, UK) by
density gradient centrifugation (Axis-Shield PoC) and plated onto gelatin-
coated tissue culture dishes in RPMI 1640 containing 5% pooled human
serum (HS; National Blood Service) at 37 C, 5% CO2. After 2 h, unat-
tached cells were washed off and the remaining adherent monocytes were
incubated overnight in RPMI 1640, 10% HS. The next day, cells were de-
tached with PBS/5 mM EDTA, washed twice in PBS, and replated in 25-
cm
2 flasks at 5–6   10
6 cells/flask. After 2 h, excess cells were removed
and the adherent cells were differentiated to macrophages in RPMI 1640,
10% HS until required. Cultures were fed every 2–3 d by replacing half of
the medium with fresh RPMI 1640, 10% HS.
Virus strains
Stocks of HIV-1 Ba-L (a gift from R. Shattock, St. Georges Hospital, Lon-
don, UK) were prepared by infecting a single preparation of MDM with
8   10
5 TCID50 for 2 h in 2 ml/25 cm
2 flask, after which the volume was
increased to 6 ml. Cell-free supernatants were collected from the infected
cultures and stored in liquid nitrogen until required. Stocks of SF162 (a gift
from A. McKnight and P. Clapham, University College London, London,
UK) were prepared likewise with an initial inoculum of 10
5 FFU/ml. Virus
stocks were titrated using the focus-forming assay described later in this
section.
Virus precipitation assay
Virus immunoprecipitation was adapted from the method described previ-
ously (Esser et al., 2001). Virus samples, diluted to 10
6 FFU/ml in PBS con-
taining 3% BSA, were mixed with the mAbs at a concentration of 10  g/ml
in a final volume of 100  l, and binding was performed overnight at 4 C.
Pansorbin cells (formalin-fixed S. aureus; Calbiochem) were preblocked
for 1 h with PBS/3% BSA, and 25  l of a 10% solution was added directly
to the virus/mAb mixture. After incubation for 30 min at RT, captured vi-
ruses were precipitated by centrifugation (4,000 rpm for 30 min). Superna-
tants were analyzed for unprecipitated infectious virus by a focus-forming
assay. Precipitated and unprecipitated material was analyzed for p24 con-
tent by ELISA.
p24 ELISA
96-well plates (Maxisorb; Nunc) were coated with 50  g/ml anti-p24
(D7320) antibody in NaCO3 coating buffer overnight. Plates were washed
several times in TBS (144 mM NaCl and 25 mM Tris, pH 7.5), and nonspe-T
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cific binding sites were blocked with 4% milk powder in TBS for 1 h. Su-
pernatants of infected cells were harvested and cell debris were removed
by centrifugation. Samples were mixed with 1% Empigen (Surfachem, Ltd.)
and incubated for at least 20 min. Multiple dilutions of the samples in 1%
Empigen in TBS were made. Serial dilutions of recombinant p24 (EVA620;
NIBSC Centralised Facility for AIDS Reagents, Potters Bar, UK) served as a
standard. The samples were bound for 4 h at RT or overnight at 4 C, fol-
lowed by several washes with TBS. Adsorbed p24 was detected with an al-
kaline phosphatase–coupled antibody (EH12-AP at 0.5  g/ml in 4% milk
powder, 20% sheep serum, and 0.5% Tween 20 in TBS) for 1 h at RT. After
extensive washing with TBS, LumiPhos
® Plus substrate (Aureon Biosys-
tems) was added for 1 h in the dark, and the enzymatic activity was mea-
sured in a luminometer (Lucy 1; Rosys Anthos) using the Stingray software
(DazDaq, Ltd.).
Reverse transcriptase assay
Reverse transcriptase activity in viral supernatants was measured using the
Lenti RT activity kit (Cavidi Tech).
Focus-forming assay
NP-2 CD4/CCR5 cells (a gift from A. McKnight and P. Clapham) were
plated in 48-well plates at a density of 1.5   10
4 cells/well, 1 d before in-
fection. Cells were infected for 3 h, washed, and cultivated for 60 h in DME
containing 5% FCS and 100 U/ m penicillin/100 mg/ l streptomycin.
Cells were fixed in methanol/acetone (1:1) and incubated for 1 h with a
mixture of two anti-HIV-1 p24 mAbs (38:97K and EF7) diluted 1:40 in PBS/
1% FCS, washed in PBS/1% FCS, and incubated for 1 h with a secondary
anti–mouse  -galactosidase–coupled antibody (2.5  g/ml in PBS/1% FCS).
After washing with PBS/1% FCS,  -galactosidase substrate solution (0.5
mg/ml 5-bromo-4-chloro-3-indolyl- -galactoside in PBS containing 3 mM
potassium ferricyanide and 1 mM magnesium chloride) was added, and the
cells were incubated overnight. Blue-stained infected cell foci were
counted microscopically and virus titers were expressed as FFU/ml.
EM immunolabeling
HIV-infected MDM or uninfected control cells were fixed by adding an
equal volume of prewarmed double-strength fixative (8% PFA in 0.1 M so-
dium phosphate buffer, pH 7.4) directly into the culture medium. After 10
min, the medium was replaced with single-strength fixative (4% PFA) for
2 h. Fixed cells were rinsed in PBS/20 mM glycine, embedded in 12% gel-
atin, infiltrated with 2.3 M sucrose, and frozen in liquid nitrogen as de-
scribed previously (Raposo et al., 1997).
Cryosections ( 50 nm) were quenched in 50 mM glycine/50 mM
NH4Cl and labeled with primary antibodies and PAG (5, 10, or 15 nm;
from The EM Lab, Utrecht University, Netherlands). Sections stained with
mouse IgG1 mAb were incubated with a rabbit anti–mouse bridging anti-
body before labeling with PAG. For double-labeling experiments, cells
were first stained with mouse IgG1 mAbs, the rabbit anti–mouse bridging
antibody, and PAG, and were fixed in 1% glutaraldehyde for 10 min be-
fore requenching and staining with a second primary antibody. When the
second primary antibody was also a mouse mAb, unoccupied binding sites
on the bridging antibody were first blocked with an irrelevant murine IgG1
(the anti-VSV-G antibody P5D4) and glutaraldehyde fixation, before stain-
ing with the second primary antibody (1B5 anti-CD63 IgG2b or 4C9 anti-
p17 IgG2a) and a second size of PAG. Sections were examined with a
transmission electron microscope (model EM420; Philips).
Immunofluorescence staining
Cells fixed in 3% PFA or semi-thin cryosections (0.5  m) were quenched
in 50 mM glycine/50 mM NH4Cl, blocked in PBS containing 0.2% gelatin
or 1% BSA, and labeled with various antibodies diluted in the blocking
buffer. Cells or sections were washed and stained with fluorescent second-
ary antibodies, washed extensively, and mounted in moviol. For permeabi-
lized cells, 0.05% saponin was added to the blocking step and each anti-
body incubation.
FACS
®
Cells were incubated in blocking buffer (PBS containing 1% FCS, 0.01%
NaN3, and 10  g/ml human IgG), for 1 h at 4 C and gently scraped off the
dish. Primary antibodies were diluted in blocking buffer to a final concen-
tration of 10  g/ml. The secondary antibodies (Alexa
® Fluor 488–conju-
gated goat anti–mouse, or goat anti–rat rhodamine) were diluted in PBS
containing 1% FCS and 0.01% NaN3. Antibody incubations were per-
formed at 4 C for 1 h, and were followed by several washes in PBS, 1%
FCS, and 0.01% NaN3. Cells were fixed overnight in PBS, 1% PFA, 2%
FCS, and 0.02% NaN3, and were analyzed using a FACSCalibur™ flow cy-
tometer (Becton Dickinson).
Online supplemental material
Table SI lists the antibodies used in this work and their sources. Online
supplemental material available at http://www.jcb.org/cgi/content/full/
jcb.200304008/DC1.
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